RT Book, Section
A1 Weiss, Robert A.
A1 Weiss, Margaret A.
A1 Beasley, Karen L.
SR Print(0)
ID 1175621171
T1 Facial Veins
T2 Sclerotherapy and Vein Treatment, 2e
YR 2012
FD 2012
PB McGraw Hill LLC
PP New York, NY
SN 9780071485425
LK dermatology.mhmedical.com/content.aspx?aid=1175621171
RD 2024/04/24
AB Many  patients  who  present  for  treatment  of  leg  veins  are  also  concerned  about  appearance  of  vascular  lesions  on  the  face.  We  estimate  that  approximately  50  percent  of  patients  seen  for  evaluation  of  leg  veins  have  some  form  of  vascular  cosmetic  blemish  on  the  face.  These  blemishes  commonly  include  telangiectasias  that  are  both  individual  and  relatively  isolated  or  large  groups  of  matted  telangiectasias  on  the  cheeks.  Cherry  hemangiomas  are  also  seen,  which  are  small,  round,  red  to  purple,  dome-shaped  vascular  ectasias  scattered  anywhere  on  the  face  or  body.  In  addition,  some  patients  develop  enlargement  of  venulectases  that  appear  as  purplish  vessels  on  the  cheeks,  periorbital  region,  vermillion,  and  nasal  alae.  A  standard  terminology  has  been  proposed  that  divides  vascular  lesions  into  hemangiomas,  malformations,  and  ectasias.1–4